The Effect of Oral Administration of Amantadine on Neurological Outcome of Patients With Diffuse Axonal Injury in ICU
Journal of Experimental Neuroscience · 2019-01 · 13
DOI: 10.1177/1179069518824851 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Neuroscience, online erschienen am 27.01.2019. Verfasst von Rahman Abbasivash und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Urmia University of Medical Sciences, Urmia, Iran. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Traumatic brain injury is a major cause of death and disability in adults. This study investigated the effect of oral administration of amantadine on the neurological outcomes of patients with diffuse axonal injury (DAI) in the intensive care unit (ICU). This double-blind clinical trial was conducted in the ICU of Imam Hospital in Urmia. Patients with DAI were intubated and received mechanical ventilation in the ICU. They were divided into 2 groups: patients receiving amantadine (A) and placebo (P). The acquired data were analyzed using SPSS, P < .05 significant level. Findings showed no significant difference between the 2 groups in age and sex. There was no significant difference between the mean Glasgow Coma Scale (GCS) at the time of admission and discharge, and the mean Glasgow Outcome Scale (GOS) of the patients in 2 groups. No significant difference was observed in the duration of mechanical ventilation, hospitalization, and mortality in both groups ( P > .05) in ICU. However, there was a significant difference between the mean GCS at the time of admission and discharge and death. Also, significant differences existed between the mean GOS in discharged and deceased patients ( P = .001). This study showed no significant difference between the mean GCS at the time of admission and discharge and the mean GOS of the discharged patients and the mortality rate in the 2 groups. However, there were clear statistical differences between these variables in discharged and deceased patients. It is recommended that further studies are conducted with a larger sample size.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, Urmia University of Medical Sciences, Urmia, Iran.
- Department of Neurosurgery, Urmia University of Medical Sciences, Urmia, Iran.
ORCID-Profile: Mohammad Amin Valizade Hasanloei
Zitieren
APA
Abbasivash, R., Valizade Hasanloei, M. A., Kazempour, A., Mahdkhah, A., Shaaf Ghoreishi, M. M., & Akhavan Masoumi, G. (2019). The Effect of Oral Administration of Amantadine on Neurological Outcome of Patients With Diffuse Axonal Injury in ICU. Journal of Experimental Neuroscience, 13. https://doi.org/10.1177/1179069518824851
Vancouver
Abbasivash R, Valizade Hasanloei MA, Kazempour A, Mahdkhah A, Shaaf Ghoreishi MM, Akhavan Masoumi G. The Effect of Oral Administration of Amantadine on Neurological Outcome of Patients With Diffuse Axonal Injury in ICU. Journal of Experimental Neuroscience. 2019;13. doi:10.1177/1179069518824851
BibTeX
@article{Abbasivash2019,
author = {Abbasivash, Rahman and Valizade Hasanloei, Mohammad Amin and Kazempour, Aidin and Mahdkhah, Ata and Shaaf Ghoreishi, Mir Mehdi and Akhavan Masoumi, Ghazal},
title = {The Effect of Oral Administration of Amantadine on Neurological Outcome of Patients With Diffuse Axonal Injury in ICU},
journal = {Journal of Experimental Neuroscience},
year = {2019},
volume = {13},
doi = {10.1177/1179069518824851}
}
EUVIMED